See also this year's filing and all EDGAR filings for this company.
PDF Report 0001087294_2026_Cumberland_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001087294, Cumberland Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 37,060,267 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 14,941,921 |
| 2 | PropertyPlantAndEquipmentNet | 264,724 |
| 3 | remainder_Assets | 24,557,080 |
| 4 | LiabilitiesCurrent | 36,744,919 |
| 5 | LiabilitiesNoncurrent | 10,294,118 |
| 6 | remainder_Liabilities | 5,240,733 |
| 7 | CostOfGoodsAndServicesSold | 6,677,894 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,957,971 |
| 9 | ResearchAndDevelopmentExpense | 5,500,560 |
| 10 | remainder_Expenses | 23,449,125 |
| 11 | remainder_Revenues | 44,032,515 |
| 12 | remainder_NetIncome | 503,739 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 76,823,992 |
| 1 | Liabilities | 52,279,770 |
| 2 | Expenses | 47,585,550 |
| 3 | Revenues | 44,032,515 |
| 4 | StockholdersEquity | 24,544,222 |
| 5 | NetIncome | -3,049,296 |
| 6 | ComprehensiveNetIncome | -3,049,296 |
| 7 | BaseVar | 110,612,783 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.782 |
| 9 | EconomicCapitalRatio | 2.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
